Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Ernexa Therapeutics Inc. (ERNA) had Weighted-Average Shares Outstanding (Diluted) of 5.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.15M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
$-0.64M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-3.14M |
|
$-2.50M |
|
$-2.45M |
|
5.18M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.18M |
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$4.79M |
|
$0.05M |
|
$2.79M |
|
$7.58M |
|
$2.65M |
|
-- |
|
$0.49M |
|
$3.14M |
|
$4.44M |
|
$2.40M |
|
$4.44M |
|
7.48M |
|
| Cash Flow Statement Financials | |
$-4.60M |
|
-- |
|
$7.18M |
|
$1.73M |
|
$4.32M |
|
$2.59M |
|
$1.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-70.65% |
|
-130.79% |
|
-41.39% |
|
-70.63% |
|
$0.59 |
|
$-0.89 |
|
$-0.89 |
|